Lyra Therapeutics Inc. (LYRA)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
Perceptive Advisors

Joseph Edelman

12,757,562 $79,352,035 1.37%
2. 4,339,101 $26,989,209 +52% 0%
3.
Nantahala Capital Management

Wilmot B. Harkey And Daniel Mack

2,820,982 $17,546,508 -31% 1%
4.
Samsara BioCapital

Srini Akkaraju And Michael Dybbs

2,780,261 $17,293,223 2.67%
5. 2,742,460 $17,058,101 -9% 0.04%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$2.96 25,000 261,966 2023-11-10 Filing
$2.43 1,203,612 Large Shareholder 2,521,745 2023-05-31 Filing
$2.43 197,946 Large Shareholder 1,107,370 2023-05-31 Filing
$2.43 403,858 Large Shareholder 2,259,301 2023-05-31 Filing
$2.43 1,203,612 Large Shareholder, Director 2,521,745 2023-05-31 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$16.00 16,909 Large Shareholder 457,421 2020-05-05 Filing
$16.00 7,255 Large Shareholder 478,123 2020-05-05 Filing
$16.00 5,568 Large Shareholder 324,057 2020-05-05 Filing
$16.00 11,360 Large Shareholder 661,153 2020-05-05 Filing
$16.00 7,255 Large Shareholder, Director 478,123 2020-05-05 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 2,575,593 $13,496,107 0.92%
2. 1,888,720 $9,896,893 8.15%
3. 1,071,460 $5,614,450 0%
4. 336,458 $1,763,416 0%
5. 301,533 $1,580,033 0%
News See All